These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25212472)

  • 21. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
    Watson B; Conigrave KM; Wallace C; Whitfield JB; Wurst F; Haber PS
    Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
    Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relapse prevention group therapy for paedophiles: French adaptation].
    Smith J; Petibon C
    Encephale; 2005; 31(5 Pt 1):552-8. PubMed ID: 16598959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France.
    Vidal-Trecan G; Varescon I; Nabet N; Boissonnas A
    Drug Alcohol Depend; 2003 Mar; 69(2):175-81. PubMed ID: 12609698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are patients' pejorative representations of buprenorphine associated with their level of addiction and of misuse?
    Vanderkam P; Gagey S; Ingrand P; Perault-Pochat MC; Brabant Y; Blanchard C; Tudrej B; Messaadi N; Binder P
    Drug Alcohol Depend; 2018 Jul; 188():10-15. PubMed ID: 29727755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia.
    Horyniak D; Dietze P; Larance B; Winstock A; Degenhardt L
    Int J Drug Policy; 2011 Mar; 22(2):167-71. PubMed ID: 21112758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Secondary benefits of cognitive rehabilitation for a chronic ethylic patient: effects on disorder consciousness, motivation, and global therapeutic cooperation].
    Siccardi L; Vautel-Pons D; dos Santos MT; Camus N; Louchart de la Chapelle S
    Encephale; 2014 Jun; 40(3):263-70. PubMed ID: 23928068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Trend in buprenorphine and methadone shopping behavior in France from 2004 to 2014].
    Kernisant M; Delorme J; Kabore JL; Brousse G; Laporte C; Zenut M; Chenaf C; Authier N
    Presse Med; 2016 Dec; 45(12 Pt 1):e369-e375. PubMed ID: 27823911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alcohol consumption in patients with psychiatric disorders: assessment and treatment].
    Lang JP; Bonnewitz ML; Kusterer M; Lalanne-Tongio L
    Encephale; 2014 Sep; 40(4):301-7. PubMed ID: 25113419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic switch to buprenorphine/naloxone from buprenorphine alone: clinical experience in an Italian addiction centre.
    Montesano F; Zaccone D; Battaglia E; Genco F; Mellace V
    Clin Drug Investig; 2010; 30 Suppl 1():13-9. PubMed ID: 20450241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France.
    Roux P; Rojas Castro D; Ndiaye K; Briand Madrid L; Laporte V; Mora M; Maradan G; Morel S; Spire B; Carrieri P
    Subst Abuse Treat Prev Policy; 2017 Nov; 12(1):46. PubMed ID: 29096661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homelessness and high-dosage buprenorphine misuse.
    Blanchon T; Boissonnas A; Vareseon I; Vidal-Trecan G
    Subst Use Misuse; 2003; 38(3-6):429-42. PubMed ID: 12747392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe upper limb complications from parenteral abuse of Subutex.
    Loo HW; Yam AK; Tan TC; Peng YP; Teoh LC
    Ann Acad Med Singap; 2005 Oct; 34(9):575-8. PubMed ID: 16284682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why do the clients of Georgian needle exchange programmes inject buprenorphine?
    Otiashvili D; Zabransky T; Kirtadze I; Piralishvili G; Chavchanidze M; Miovsky M
    Eur Addict Res; 2010; 16(1):1-8. PubMed ID: 19887803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Puffy hand syndrome: A little-known diagnosis].
    Chantalat L; Simon M; Fourgeaud C; Vignes S
    Rev Med Interne; 2020 Oct; 41(10):700-703. PubMed ID: 32674894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Severe distal ischemic syndrome after buprenorphine volunteer intra-arterial injection].
    Glaizal M; Lucciardi J; Tichadou L; Spadari M; Hayek-Lanthois M; Micallef J; de Haro L
    Therapie; 2011; 66(6):545-7. PubMed ID: 22186079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.
    Maremmani I; Gerra G
    Am J Addict; 2010; 19(6):557-68. PubMed ID: 20958853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.